Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn’s Disease With up to 6 Years of Follow-Up in the Pyramid Registry
D’Haens, Geert, Reinisch, Walter, Panaccione, Remo, Satsangi, Jack, Petersson, Joel, Bereswill, Mareike, Arikan, Dilek, Perotti, Eva, Robinson, Anne M, Kalabic, Jasmina, Alperovich, Gabriela, Thakkar,Langue:
english
Journal:
The American Journal of Gastroenterology
DOI:
10.1038/s41395-018-0098-4
Date:
June, 2018
Fichier:
PDF, 1.18 MB
english, 2018
File converter
Plus de résultats de recherche
More benefits 
